Tina Termini, Assistant Professor at Fred Hutch, shared a post on X:
“Excited to share recent work from our lab in Blood Journals Portfolio.
Blood Advances! We studied the impact of CD45-targeted radioimmunotherapy (RIT) on the bone marrow vascular niche. Turns out the vasculature is majorly disrupted by hematopoietic targeted RIT.”
Title: The bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapy
Authors: Matthew W. Hagen, Nicollette J. Setiawan, Shannon Dexter, Kelsey A. Woodruff, Francesca K. Gaerlan, Taylor M. Billings, Johnnie J. Orozco, Christina M. Termini
Other articles on OncoDaily.
